Last updated: April 2026
Willow vs MyStart: Compare GLP-1 Programs & Pricing
Side-by-side Willow and MyStart: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Willow and MyStart are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares Willow vs MyStart to help you identify which platform best fits your health goals, budget, and preferred level of clinical support.
Willow vs MyStart: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Willow | $299.00 | $399.00 | Best for Oral and Injectable (Code: ) | — No |
| MyStart | $179.00 | $299.00 | (Code: EXPLORE2026) | — |
Willow vs MyStart: Medical Process & Accessibility
Willow emphasizes a rapid telehealth intake that can be completed in as little as 10 minutes, after which a licensed clinician reviews your health questionnaire and either approves or requests additional information. Once approved, prescriptions are sent electronically to a partnered U.S. pharmacy that compounds the GLP‑1 medication and ships it directly to your door.
MyStart follows a slightly longer onboarding flow that includes a video consultation, a baseline labs request (optional but recommended), and a structured follow‑up schedule. The program is designed for patients who want more hands‑on dose titration and regular check‑ins, which can be especially valuable for those new to GLP‑1 therapy.
Willow vs MyStart: Pricing Comparison
The headline numbers are simple: Willow starts semaglutide at $299.00 and tirzepatide at $399.00. MyStart offers semaglutide for $179.00 and tirzepatide for $299.00. Because the MyStart prices are lower for both medications, they are bolded for quick visual reference.
Both providers may offer introductory discounts. Willow advertises a “Best for Oral and Injectable” promo (no specific code required) that can be applied at checkout. MyStart provides a clear discount code—EXPLORE2026—which reduces the first month’s cost according to the latest pricing sheet.
Willow vs MyStart: Clinical Oversight & Support
Both platforms employ board‑certified physicians, nurse practitioners, or physician assistants who are licensed in the state where you reside. After the initial prescription, Willow typically schedules a follow‑up call at 30 days, while MyStart builds in monthly virtual visits for the first three months to fine‑tune dosing and monitor side‑effects.
Book a Consultation with Willow
Willow vs MyStart: Medication Quality & Safety
Both companies compound semaglutide and tirzepatide in FDA‑registered pharmacies that follow Good Manufacturing Practices (GMP). These compounded products are legally dispensed when a qualified prescriber writes the order, and they are considered therapeutically equivalent to the branded versions (e.g., Wegovy® or Mounjaro®) for most patients.
All telehealth interactions comply with FDA regulations for remote prescribing, and each provider includes a detailed medication guide that outlines dosing, potential adverse effects, and contraindications.
Willow vs MyStart: Customer Experience & Delivery
Customer reviews on independent forums suggest that Willow’s biggest strengths are its low entry price and swift shipping—most users receive their first dose within 5‑7 business days after approval. MyStart receives praise for its personalized coaching, regular check‑ins, and transparent communication about insurance and out‑of‑pocket costs.
Willow vs MyStart: Membership & Ongoing Costs
Neither provider charges a mandatory monthly membership fee. Willow explicitly states “No” under membership, and MyStart does not list any recurring subscription cost. However, patients should be aware that each refill cycle (typically 30‑day supply) incurs the same per‑medication price shown above, and optional lab panels or extra coaching sessions may carry additional fees.
When budgeting, consider the cumulative cost of medication, any lab work, and occasional telehealth visits. For many users, the lower medication price from MyStart results in a modest overall savings despite the potentially higher level of clinical interaction.
Join Willow
Get Started with MyStart
Willow vs MyStart: Final Verdict
If you prioritize a low‑cost entry point, rapid onboarding, and a straightforward medication‑only program, Willow is the clear choice. If you value ongoing clinical guidance, more frequent dose adjustments, and are comfortable with a slightly higher—but still competitive—price, MyStart may better align with your needs.
Both platforms are FDA‑compliant, operate under licensed telehealth regulations, and provide safe access to GLP‑1 therapies across the United States. Your decision should ultimately reflect your personal health goals, preferred level of medical support, and budget.
Choose Willow Today
Start with MyStart
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.
Recommended next step
Review the latest provider details before you decide.